Dr Hilda High, Genetic Oncologist
MBBS (Hons), MCH, FRACP
Dr Hilda High High is head of Sydney Cancer Genetics and sees patients via bulk billed TeleHealth consults throughout rural and regional Australia and face-to face clinics in Sydney.
Dr Hilda High completed her medical degree at Sydney University with honours. She is a registered medical oncologist specialising in cancer genetics. She has worked with familial cancer services at the Prince of Wales Hospital, Westmead Hospital and Royal North Shore Hospitals.
Hilda is a unpaid founding director of The Cancer Genetics Fund. The Cancer Genetics Fund is a registered charity that was formed to prevent cancer and its effect on individuals and families by promoting awareness of hereditary cancer syndromes and their management. It also hosts the free ClinTrial Refer Cancer Genetics App which provides access to hereditary cancer research trials, regardless of where you live.
Hilda has a keen interest in research. She has presented her work at national and international conferences and has published in key international journals. She completed her Master of Community Health, for which she won the Master of Community Health Prize, through the University of NSW.
Combining her knowledge and passion for both genetics and oncology, Hilda is an enthusiastic speaker, providing lectures and talks to medical students, nurses, registrars, GP’s and specialists. Her presentations also include talks to special interest groups such as those affected by BRCA1 or BRCA2 mutations through organisations such as Association of Genetic Support of Australasia (AGSA)
Hilda is a caring and sympathetic doctor. During her training at Westmead Hospital, she was awarded The Dominque Clancey and Andrew Donald Memorial Prize: “in recognition of her dedication, selflessness and commitment to others”. She is aware of the emotional issues that can arise when discussing family cancer histories as well as the sometimes complicated dynamics of a modern family.
Hilda previously worked as an HIV specialist dietitian and was awarded the Mead Johnson Achiever’s Award from the Dietitians Association of Australia and Bristol Myers Squibb for “leadership, expertise and service to the profession”. She is skilled in working in sensitive areas requiring privacy, confidentiality and compassion.
She is a key member of the Cancer Institutes eviQ group, working with national experts to provide standardised Australian guidelines for the testing and management of inherited disorders associated with cancer. Her professional memberships have included: the Medical Oncology Group of Australia (MOGA), the American Society of Clinical Oncology (ASCO), the Human Genetics Organisation (HUGO) and the Private Cancer Physicians Australia (PCPA).